RecallRadar

FDA Drug recall D-1330-2022

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distribu…

On 2022-08-17 the FDA classified a Class II recall of Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distribu… by Strides Pharma, citing presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1330-2022
ClassificationClass II
Statusterminated
Initiated2022-07-19
Published2022-08-17
Last updated2026-09-13 11:52 UTC
CompanyStrides Pharma
DistributionUS

Product

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.

Reason

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Identifiers

ndc64380-784-01
ndc64380-784-07
ndc64380-784-08
ndc64380-784-06
ndc64380-785-06
ndc64380-785-07
ndc64380-785-08
ndc64380-785-01
ndc64380-949-06
ndc64380-949-01
code_infoLot #: 7248988B, Exp 9/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1330-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.